IP20-20: Prospective Validation of BIAS and IBCG Scoring Systems for Predicting High-Grade Progression in Intermediate-Risk Non–Muscle-Invasive Bladder Cancer initially Eligible for Active Surveillance

IP20-20: Prospective Validation of BIAS and IBCG Scoring Systems for Predicting High-Grade Progression in Intermediate-Risk Non–Muscle-Invasive Bladder Cancer initially Eligible for Active Surveillance

Friday, May 15, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!